Lei et al. reported that ABHD11-AS1 interacts with miR-133a, which acts as a tumor suppressor in CRC by targeting LIM, SH3 protein 1, and inhibiting the mitogen-activated protein kinase (MAPK) pathway [27,80]. This evidence concerns the gene ABHD11 and neoplasm.